IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RDHL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Redhill Biopharma Ltd. stock price down 4.98% on Monday
(Updated on Apr 15, 2024)

Sell candidate since Apr 08, 2024 Loss -22.86% PDF

The Redhill Biopharma Ltd. stock price fell by -4.98% on the last day (Monday, 15th Apr 2024) from $0.425 to $0.404. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 8.26% from a day low at $0.403 to a day high of $0.437. The price has fallen in 8 of the last 10 days and is down by -26.48% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -227 thousand shares and in total, 317 thousand shares were bought and sold for approximately $128.04 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.67% during the next 3 months and, with a 90% probability hold a price between $0.160 and $0.506 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

RDHL Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Redhill Biopharma Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.474 and $0.522. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -26.48%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Redhill Biopharma Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0333 between high and low, or 8.26%. For the last week the stock has had daily average volatility of 9.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RDHL) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Redhill Biopharma Ltd. to open at $0.415, and during the day (based on 14 day Average True Range), to move between $0.367 and $0.442, which gives a possible trading interval of +/-$0.0377 (+/-9.32%) up or down from last closing price. If Redhill Biopharma Ltd. takes out the full calculated possible swing range there will be an estimated 18.65% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.425, some $0.0212 (5.24%) from the current price of $0.404, our system finds the risk reward not very attractive.

Is Redhill Biopharma Ltd. stock A Buy?

Redhill Biopharma Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.669 Strong Sell Candidate Unchanged

Predicted Opening Price for Redhill Biopharma Ltd. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$0.415 ( 2.58%) $0.404

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RDHL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.448 10.82 %
R2 0.435 7.67 %
R1 0.427 5.73 %
Current price: 0.404
Support S1 0.402 -0.566 %
S2 0.394 -2.51 %
S3 0.381 -5.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.504 24.57 %
R2 0.461 14.05 %
R1 0.425 5.24 %
Current price 0.404
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Redhill Biopharma Ltd. Stock and on which exchange is it traded?
The symbol for Redhill Biopharma Ltd. is RDHL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Redhill Biopharma Ltd. Stock?
Redhill Biopharma Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Redhill Biopharma Ltd. Stock?
Redhill Biopharma Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Redhill Biopharma Ltd. Stock.

What's the current price of Redhill Biopharma Ltd. Stock?
As of the end of day on the 2024-04-15, the price of an Redhill Biopharma Ltd. (RDHL) share was $0.404.

What is the 52-week high and low for Redhill Biopharma Ltd. Stock?
The 52-week high for Redhill Biopharma Ltd. Stock is $3.60 and the 52-week low is $0.257.

What is the market capitalization of Redhill Biopharma Ltd. Stock?
As of the 2024-04-15, the market capitalization of Redhill Biopharma Ltd. is 12.636M.

When is the next earnings date for Redhill Biopharma Ltd.?
The upcoming earnings date for Redhill Biopharma Ltd. is Aug 15, 2024.
Click to get the best stock tips daily for free!

About Redhill Biopharma Ltd.

Redhill Biopharma Ltd. RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr... RDHL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT